Skip to content
GLP-1 Desk
Menu
Dispatch #39

LillyDirect Foundayo

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

Visit LillyDirect FoundayoAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Yes

Line LillyDirect Foundayo up against its closest alternatives. Or go one-on-one: LillyDirect Foundayo vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency86/100
State access86/100
Molecule range69/100
Onboarding speed86/100
Support responsiveness71/100
Licensing & trust97/100

What the Desk likes

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where points come off

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

The Desk's briefing — B−

Best for: Patients with commercial insurance who want the cheapest legal brand-name GLP-1.

LillyDirect Foundayo ranks #39 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (24)

Pricing and verification reflect LillyDirect Foundayo's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on LillyDirect Foundayo's site. Not medical advice; see our disclosure.

← Back to The Desk